GO:1904510 positive regulation of protein localization to basolateral plasma membrane: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904510 describes any process that increases the frequency, rate, or extent of protein localization to the basolateral plasma membrane, a key event for epithelial polarity and tissue architecture.
• The term is a biological_process child of 'positive regulation of protein localization to plasma membrane' and is essential for establishing and maintaining the basolateral domain in polarized cells.
• Key molecular players include RAB-10, EHBP-1, CD147, PARP12, Golgin-97, Cdc42, Rab11a, VAMP2, Dlg, Erbin, NHERF1, Ezrin, ErbB2, and DLC3, which coordinate vesicle capture, cytoskeletal tethering, and membrane fusion.
• Dysregulation of basolateral protein targeting is linked to hepatocellular carcinoma progression, HER2-positive breast cancer, and other epithelial cancers.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are powerful tools to dissect the causal roles of these genes in basolateral trafficking.
• EDITGENE provides end-to-end CRISPR services, including library screening and bioinformatics, to accelerate research on GO:1904510-related pathways.
Description
The basolateral plasma membrane is a specialized domain of polarized epithelial cells that faces the basement membrane and adjacent cells, and its unique protein composition is essential for vectorial transport, cell adhesion, and tissue integrity. The Gene Ontology term GO:1904510, 'positive regulation of protein localization to basolateral plasma membrane', captures the regulatory processes that enhance the delivery of proteins to this domain, a step critical for epithelial polarity and function. Understanding this process is fundamental for researchers studying epithelial biology, cancer, and developmental disorders, as mislocalization of basolateral proteins can disrupt tissue architecture and drive disease. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a comprehensive overview of the mechanisms, key genes, and experimental approaches relevant to GO:1904510.
positive regulation of protein localization to basolateral plasma membrane At A Glance
| GO ID | GO:1904510 |
|---|---|
| GO term | positive regulation of protein localization to basolateral plasma membrane |
| Ontology | biological_process |
| Synonym | activation of protein localization to basolateral plasma membrane; upregulation of protein localization to basolateral plasma membrane; positive regulation of protein localisation to basolateral plasma membrane |
| Major function | Enhances the delivery and retention of proteins at the basolateral plasma membrane, supporting epithelial polarity and tissue organization. |
| Related cellular component | Basolateral plasma membrane; Golgi apparatus; recycling endosomes. |
| Related molecular functions | Small GTPase activity (Rab, Rho), vesicle tethering, membrane fusion. |
| Key regulators | RAB-10, EHBP-1, CD147, PARP12, Golgin-97, Cdc42, Rab11a, VAMP2, Dlg, Erbin, NHERF1, Ezrin, ErbB2, DLC3. |
| Disease relevance | Hepatocellular carcinoma, HER2-positive breast cancer, epithelial polarity disorders. |
What Is GO:1904510?
GO:1904510 is a biological process term defined as any process that activates or increases the frequency, rate, or extent of protein localization to the basolateral plasma membrane. In other words, it encompasses the molecular events that promote the targeted delivery and accumulation of specific proteins at the basolateral surface of polarized cells, as opposed to the apical domain. This regulation ensures the correct spatial distribution of membrane proteins, which is vital for cell polarity, signaling, and barrier function.
Why Is positive regulation of protein localization to basolateral plasma membrane Important in Cell Biology?
GO:1904510 is crucial because the basolateral plasma membrane is the site of essential cellular functions, including nutrient uptake, cell-cell adhesion, and signal transduction. The positive regulation of protein localization to this domain ensures that receptors, transporters, and adhesion molecules are correctly positioned, which is fundamental for epithelial barrier function and tissue homeostasis. Disruption of this process leads to loss of polarity, a hallmark of cancer progression and metastasis, as seen in hepatocellular carcinoma where basolateral CD147 induces E-cadherin degradation and polarity loss. Moreover, understanding the regulatory mechanisms can reveal therapeutic targets for diseases characterized by defective protein trafficking.
• Maintains epithelial cell polarity, which is essential for organ development and function.
• Ensures correct localization of adhesion molecules like E-cadherin, affecting cell-cell adhesion and tissue integrity.
• Regulates signaling receptors such as ErbB2, influencing cell proliferation and survival.
• Dysregulation is linked to cancer progression, including hepatocellular carcinoma and breast cancer.
• Involved in vesicular trafficking pathways that are conserved from C. elegans to humans.
• Provides potential targets for therapeutic intervention in trafficking-related diseases.
• Helps understand the molecular basis of polarity defects in developmental disorders.
• Facilitates the study of membrane domain specialization in various epithelia.
• Offers insights into the coordination between cytoskeleton and membrane trafficking.
• Enables the development of CRISPR models to dissect gene function in basolateral targeting.
What Happens During positive regulation of protein localization to basolateral plasma membrane?
Vesicle Capture and Tethering at the Golgi
In simple terms: After proteins are packaged into vesicles, they must be captured and held near the Golgi before moving to the basolateral membrane.
The initial step involves the recognition and capture of post-Golgi vesicular carriers. RAB-10, a small GTPase, cooperates with EHBP-1 to capture vesicular carriers during post-Golgi exocytic trafficking, ensuring that cargo destined for the basolateral membrane is properly sorted and tethered. This capture is essential for subsequent transport steps and is a key point of positive regulation.
Cytoskeletal Tethering and Transport
In simple terms: The captured vesicles are then linked to the cytoskeleton to be transported to the correct side of the cell.
Following capture, vesicles are tethered to the cytoskeleton for directed transport. Dlg, a scaffolding protein, contributes to cell polarity and tumorigenesis through electrostatic plasma membrane targeting, which helps organize the basolateral domain. Additionally, Rho regulation by DLC3 controls spatial signaling that influences cytoskeletal dynamics and vesicle movement. These interactions ensure that vesicles are delivered to the basolateral membrane with high fidelity.
Membrane Fusion and Protein Delivery
In simple terms: Finally, the vesicles fuse with the basolateral membrane, releasing their protein cargo into the membrane.
The final step is the fusion of vesicles with the basolateral plasma membrane, a process mediated by SNARE proteins. Cdc42 regulates apical membrane fusion via the Rab11a-VAMP2 pathway in salivary gland acinar cells, and similar mechanisms are thought to operate at the basolateral domain. In addition, PKD-dependent PARP12-catalyzed mono-ADP-ribosylation of Golgin-97 is required for E-cadherin transport from Golgi to plasma membrane, highlighting a specific regulatory modification that promotes basolateral delivery. This fusion event completes the positive regulation of protein localization.
Retention and Stabilization at the Basolateral Membrane
In simple terms: Once delivered, proteins are anchored and stabilized at the basolateral membrane to maintain polarity.
After delivery, proteins must be retained at the basolateral membrane. Erbin interacts with NHERF1 and Ezrin to stabilize a membrane ErbB2 signaling complex in HER2-positive breast cancer, demonstrating how scaffolding complexes can anchor receptors at the basolateral surface. This stabilization prevents mislocalization and reinforces the basolateral identity, contributing to sustained positive regulation.
Key Genes Involved in GO:1904510 positive regulation of protein localization to basolateral plasma membrane
The following genes and proteins have been experimentally implicated in the positive regulation of protein localization to the basolateral plasma membrane, based on verified PubMed literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RAB-10 | Small GTPase that captures post-Golgi vesicular carriers with EHBP-1 | Model for vesicle capture in exocytic trafficking |
| EHBP-1 | Effector of RAB-10, involved in vesicle capture | Studying protein-protein interactions in trafficking |
| CD147 | Induces hepatocyte polarity loss by E-cadherin ubiquitination and degradation | Target in hepatocellular carcinoma progression |
| PARP12 | Catalyzes mono-ADP-ribosylation of Golgin-97 for E-cadherin transport | Regulator of Golgi-to-plasma membrane transport |
| Golgin-97 | Golgi tethering factor modified by PARP12 | Essential for E-cadherin delivery to basolateral membrane |
| Cdc42 | Regulates apical membrane fusion via Rab11a-VAMP2 pathway | Model for Rho GTPase in membrane fusion |
| Rab11a | Small GTPase involved in vesicle fusion | Component of the fusion machinery |
| VAMP2 | SNARE protein mediating membrane fusion | Studying SNARE-dependent basolateral delivery |
| Dlg | Scaffolding protein with electrostatic plasma membrane targeting | Role in cell polarity and tumorigenesis |
| Erbin | Interacts with NHERF1 and Ezrin to stabilize ErbB2 complex | Breast cancer signaling and basolateral retention |
| NHERF1 | Scaffolding protein binding Erbin and Ezrin | Component of membrane complexes |
| Ezrin | Linker between membrane and cytoskeleton | Stabilizes basolateral complexes |
| ErbB2 | Receptor tyrosine kinase stabilized at membrane | HER2-positive breast cancer target |
| DLC3 | Rho GAP controlling spatial Rho regulation | Regulator of cytoskeletal dynamics |
| PKD | Kinase activating PARP12 | Upstream regulator of Golgin-97 modification |
| PMCA4 | Calcium pump localized to basolateral membrane | Model for basolateral localization in epithelia |
How Is positive regulation of protein localization to basolateral plasma membrane Regulated?
The positive regulation of protein localization to the basolateral plasma membrane is controlled by multiple signaling pathways. Small GTPases such as RAB-10 and Cdc42 act as molecular switches that orchestrate vesicle capture and fusion. Phosphorylation events, such as PKD-dependent activation of PARP12, lead to post-translational modifications of Golgi tethering factors like Golgin-97, which are required for efficient transport. Additionally, Rho GTPase signaling, modulated by GAP proteins like DLC3, influences cytoskeletal dynamics and spatial regulation of trafficking. These regulatory layers ensure that protein delivery to the basolateral membrane is tightly coordinated with cellular needs and environmental cues.
positive regulation of protein localization to basolateral plasma membrane and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CD147 | Hepatocellular carcinoma, polarity loss | Knockout or overexpression in hepatocyte cell lines |
| Erbin | HER2-positive breast cancer | Knockdown or knockout in breast cancer cells |
| Dlg | Cell polarity and tumorigenesis | Point mutations to disrupt membrane targeting |
| DLC3 | Rho regulation in cancer | Knockout in epithelial cells |
| PARP12 | Golgi-to-membrane transport in cancer | Knockout to block E-cadherin delivery |
Hepatocellular Carcinoma
In hepatocellular carcinoma, basolateral CD147 induces hepatocyte polarity loss by promoting E-cadherin ubiquitination and degradation, leading to disrupted tissue architecture and tumor progression. This highlights how aberrant positive regulation of basolateral protein localization can contribute to cancer.
HER2-Positive Breast Cancer
Erbin interacts with NHERF1 and Ezrin to stabilize a membrane ErbB2 signaling complex in HER2-positive breast cancer, suggesting that basolateral retention of ErbB2 enhances oncogenic signaling. Targeting this stabilization complex may offer therapeutic opportunities.
Epithelial Polarity Disorders
Defects in the machinery that regulates basolateral protein targeting, such as mutations in Dlg or DLC3, can lead to loss of cell polarity and contribute to developmental disorders and tumorigenesis. Understanding these mechanisms is crucial for diagnosing and treating polarity-related diseases.
From positive regulation of protein localization to basolateral plasma membrane-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does RAB-10 capture vesicles for basolateral delivery? | Knockout of RAB-10 in C. elegans or mammalian cells |
| How does CD147 induce polarity loss? | Overexpression of CD147 in hepatocytes |
| Is PARP12-mediated ADP-ribosylation required for E-cadherin transport? | Point mutation of Golgin-97 at modification site |
| Does Cdc42 regulate basolateral fusion? | Knockout of Cdc42 in salivary gland cells |
| How does Dlg membrane targeting affect polarity? | Point mutations in Dlg electrostatic domain |
| Can Erbin stabilization be disrupted therapeutically? | Knock-in of tagged Erbin for interaction studies |
How to Study the positive regulation of protein localization to basolateral plasma membrane Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Dynamics of vesicle trafficking and fusion | Real-time tracking of basolateral delivery |
| Proteomics | Protein composition of basolateral membranes | Identifying cargo and regulators |
| CRISPR screen | Genes affecting basolateral localization | Discovery of novel regulators |
| Immunohistochemistry | Spatial distribution of proteins in tissues | Validating basolateral localization in vivo |
| Electron microscopy | Ultrastructure of membrane domains | High-resolution mapping of basolateral membrane |
| Co-immunoprecipitation | Protein-protein interactions | Identifying complexes like Erbin-NHERF1-Ezrin |
| GTPase activity assays | Activation state of small GTPases | Measuring RAB-10 or Cdc42 activity |
| RNA-seq | Transcriptional changes upon perturbation | Assessing gene expression in polarity loss |
Live-Cell Imaging of Vesicle Trafficking
Live-cell imaging using fluorescently tagged cargo proteins and vesicle markers allows real-time visualization of protein delivery to the basolateral membrane. This method can reveal the dynamics of vesicle capture, transport, and fusion, as demonstrated for RAB-10 and EHBP-1.
Proteomic Analysis of Basolateral Membranes
Isolation of basolateral plasma membrane fractions followed by mass spectrometry can identify the protein composition and changes in localization upon genetic perturbations. This approach helps quantify the positive regulation of protein localization.
CRISPR Screening for Trafficking Regulators
Genome-wide CRISPR knockout or activation screens can identify genes that positively regulate basolateral protein localization. Hits can be validated by imaging and biochemical assays, as shown for Golgin-97 and PARP12.
Immunohistochemistry and Electron Microscopy
Immunohistochemical localization of specific proteins, such as PMCA4, in epithelial tissues provides spatial information about basolateral distribution. Electron microscopy can reveal ultrastructural details of membrane domains.
How CRISPR Can Be Used to Study GO:1904510 positive regulation of protein localization to basolateral plasma membrane
Knockout
CRISPR knockout of genes such as RAB-10, EHBP-1, or PARP12 can abolish positive regulation of basolateral protein localization, leading to mislocalization of cargo and loss of polarity. These models are essential to establish causality and are widely used in trafficking research.
Point Mutation
Introducing point mutations in key residues, such as the catalytic site of PARP12 or the electrostatic domain of Dlg, allows precise dissection of molecular mechanisms without completely eliminating protein expression. This approach can reveal phosphorylation or modification sites critical for basolateral targeting.
Knock-in
Knock-in of tagged versions of proteins like Erbin or Golgin-97 enables live-cell imaging and biochemical isolation of complexes, providing insights into their dynamic localization and interactions during basolateral transport.
Overexpression
Overexpression of CD147 or ErbB2 can induce polarity loss or enhance oncogenic signaling, mimicking disease states. These models help study the consequences of excessive basolateral protein delivery and identify therapeutic targets.
How EDITGENE Supports positive regulation of protein localization to basolateral plasma membrane Research
Researchers studying positive regulation of protein localization to basolateral plasma membrane-related genes often need to determine whether a candidate gene is causally involved in trafficking, polarity, or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of protein localization to basolateral plasma membrane research.
Frequently Asked Questions About positive regulation of protein localization to basolateral plasma membrane
What is GO:1904510?
GO:1904510 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate, or extent of protein localization to the basolateral plasma membrane.
What genes are involved in positive regulation of protein localization to basolateral plasma membrane?
Key genes include RAB-10, EHBP-1, CD147, PARP12, Golgin-97, Cdc42, Rab11a, VAMP2, Dlg, Erbin, NHERF1, Ezrin, ErbB2, and DLC3, as identified in various studies.
Why is basolateral protein localization important?
It is essential for epithelial cell polarity, tissue architecture, and proper signaling, and its disruption is linked to cancer and other diseases.
How is protein localization to the basolateral membrane regulated?
It is regulated by small GTPases, kinases, and post-translational modifications that control vesicle capture, transport, and fusion at the basolateral domain.
What diseases are associated with defects in basolateral protein targeting?
Hepatocellular carcinoma, HER2-positive breast cancer, and epithelial polarity disorders have been associated with misregulation of this process.
What experimental models are used to study GO:1904510?
CRISPR knockout, point mutation, knock-in, and overexpression cell models, as well as live-cell imaging and proteomics, are commonly used.
How can CRISPR help study basolateral protein localization?
CRISPR allows precise genetic manipulation to test the causal role of specific genes in basolateral trafficking and to create disease-relevant models.
What is the role of RAB-10 in basolateral transport?
RAB-10 cooperates with EHBP-1 to capture vesicular carriers during post-Golgi exocytic trafficking, a key step in basolateral delivery.
How does CD147 affect hepatocyte polarity?
CD147 induces hepatocyte polarity loss by promoting E-cadherin ubiquitination and degradation, disrupting basolateral adhesion.
What services does EDITGENE offer for studying GO:1904510?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services to support research on basolateral protein localization.
Conclusion
GO:1904510, positive regulation of protein localization to basolateral plasma membrane, is a fundamental biological process that ensures correct protein targeting in polarized epithelial cells. Dysregulation of this process contributes to cancer and other diseases, making it a critical area of research. By leveraging CRISPR-based models and advanced imaging and proteomic techniques, researchers can dissect the molecular mechanisms and identify therapeutic targets. EDITGENE stands ready to support these efforts with tailored CRISPR services.
References
- 1. Liu S et al.. 2025. RAB-10 cooperates with EHBP-1 to capture vesicular carriers during post-Golgi exocytic trafficking.. J Cell Biol 224(4) PMID: 39982707
- 2. Lu M et al.. 2018. Basolateral CD147 induces hepatocyte polarity loss by E-cadherin ubiquitination and degradation in hepatocellular carcinoma progress.. Hepatology 68(1):317-332 PMID: 29356040
- 3. Alexander RT et al.. 2015. Ultrastructural and immunohistochemical localization of plasma membrane Ca2+-ATPase 4 in Ca2+-transporting epithelia.. Am J Physiol Renal Physiol 309(7):F604-16 PMID: 26180241
- 4. Grimaldi G et al.. 2022. PKD-dependent PARP12-catalyzed mono-ADP-ribosylation of Golgin-97 is required for E-cadherin transport from Golgi to plasma membrane.. Proc Natl Acad Sci U S A 119(1) PMID: 34969853
- 5. Shitara A et al.. 2025. Cdc42 regulates apical membrane fusion via the Rab11a-VAMP2 pathway in salivary gland acinar cells.. bioRxiv PMID: 41031016
- 6. Lu J et al.. 2021. Electrostatic plasma membrane targeting contributes to Dlg function in cell polarity and tumorigenesis.. Development 148(7) PMID: 33688074
- 7. Jeong J et al.. 2025. Erbin interacts with NHERF1 and Ezrin to stabilize a membrane ErbB2 signaling complex in HER2-positive breast cancer.. Breast Cancer Res 27(1):85 PMID: 40390040
- 8. Hendrick J et al.. 2019. Spatial Rho regulation: Molecular mechanisms controlling the GAP protein DLC3.. Small GTPases 10(1):13-19 PMID: 27849131
